Malini Guha

578 total citations
22 papers, 456 citations indexed

About

Malini Guha is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Malini Guha has authored 22 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Malini Guha's work include Advanced Breast Cancer Therapies (4 papers), Cinema and Media Studies (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Malini Guha is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cinema and Media Studies (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Malini Guha collaborates with scholars based in Canada and United States. Malini Guha's co-authors include Elina Jerschow, Sunit Jariwala and Paul Riska and has published in prestigious journals such as Nature Biotechnology, Nature Reviews Drug Discovery and JNCI Journal of the National Cancer Institute.

In The Last Decade

Malini Guha

19 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malini Guha Canada 10 289 198 70 63 46 22 456
Liv Johannessen United States 8 241 0.8× 152 0.8× 34 0.5× 57 0.9× 42 0.9× 19 374
Nahee Park South Korea 11 186 0.6× 146 0.7× 56 0.8× 109 1.7× 24 0.5× 15 347
Brian Zifcak United States 7 431 1.5× 136 0.7× 43 0.6× 45 0.7× 125 2.7× 10 570
Vincent A. de Weger Netherlands 11 211 0.7× 334 1.7× 50 0.7× 94 1.5× 38 0.8× 26 551
Murray Yule United States 12 335 1.2× 211 1.1× 76 1.1× 89 1.4× 29 0.6× 31 575
Mary Luz Uribe Spain 8 259 0.9× 153 0.8× 35 0.5× 104 1.7× 45 1.0× 14 513
Reginald B. Ewesuedo United States 11 233 0.8× 216 1.1× 139 2.0× 22 0.3× 35 0.8× 29 450
Naoto Ohi Japan 12 276 1.0× 169 0.9× 57 0.8× 30 0.5× 86 1.9× 19 519
Tahir Sheikh United States 8 335 1.2× 162 0.8× 35 0.5× 48 0.8× 23 0.5× 19 431

Countries citing papers authored by Malini Guha

Since Specialization
Citations

This map shows the geographic impact of Malini Guha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malini Guha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malini Guha more than expected).

Fields of papers citing papers by Malini Guha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malini Guha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malini Guha. The network helps show where Malini Guha may publish in the future.

Co-authorship network of co-authors of Malini Guha

This figure shows the co-authorship network connecting the top 25 collaborators of Malini Guha. A scholar is included among the top collaborators of Malini Guha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malini Guha. Malini Guha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guha, Malini. (2021). Assemblage, Performance, Precarity. 7(3). 82–103.
2.
Guha, Malini. (2020). World Cinema 3.0? The “World as Backdrop” for a Multimedial Age. Canadian Journal of Film Studies. 29(2). 37–51.
3.
Guha, Malini. (2017). Misunderstanding the Bad Luck of Getting Cancer. JNCI Journal of the National Cancer Institute. 109(6). 1 indexed citations
4.
Guha, Malini. (2015). HDAC inhibitors still need a home run, despite recent approval. Nature Reviews Drug Discovery. 14(4). 225–226. 101 indexed citations
5.
Guha, Malini. (2015). From Empire to the World. Edinburgh University Press eBooks. 2 indexed citations
6.
Guha, Malini. (2015). Erratum: HDAC inhibitors still need a home run, despite recent approval. Nature Reviews Drug Discovery. 14(5). 365–365. 8 indexed citations
7.
Guha, Malini. (2015). From Empire to the World: Migrant London and Paris in the Cinema. 1 indexed citations
8.
Guha, Malini. (2014). Imbruvica—next big drug in B-cell cancer—approved by FDA. Nature Biotechnology. 32(2). 113–114. 10 indexed citations
9.
Guha, Malini. (2014). Novartis' lung cancer ALK inhibitor approved. Nature Biotechnology. 32(7). 607–607. 3 indexed citations
10.
Guha, Malini, et al.. (2013). Toxocariasis presenting as eosinophilic ascites in a post-partum female. Journal of Parasitic Diseases. 39(2). 284–286. 5 indexed citations
11.
Guha, Malini. (2013). Urea cycle disorder drug approved. Nature Biotechnology. 31(4). 274–274. 11 indexed citations
12.
Guha, Malini. (2013). Amgen swallows Onyx whole. Nature Biotechnology. 31(10). 859–860. 2 indexed citations
13.
Guha, Malini. (2013). Blockbuster dreams for Pfizer's CDK inhibitor. Nature Biotechnology. 31(3). 187–187. 38 indexed citations
14.
Guha, Malini. (2013). First-in-class guanylate cyclase stimulator approved for PAH. Nature Biotechnology. 31(12). 1064–1064. 15 indexed citations
15.
Guha, Malini. (2012). Cyclin-dependent kinase inhibitors move into Phase III. Nature Reviews Drug Discovery. 11(12). 892–894. 62 indexed citations
16.
Guha, Malini. (2012). Analysis affirms secondary cancer risk with lenalidomide. The Lancet Oncology. 13(2). e54–e54. 1 indexed citations
17.
Guha, Malini. (2012). AACR annual meeting 2012. The Lancet Oncology. 13(5). 454–454. 6 indexed citations
18.
Guha, Malini. (2012). Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential. Nature Reviews Drug Discovery. 11(4). 257–258. 28 indexed citations
19.
Guha, Malini. (2012). Anticancer TLR agonists on the ropes. Nature Reviews Drug Discovery. 11(7). 503–505. 44 indexed citations
20.
Guha, Malini. (2011). PARP inhibitors stumble in breast cancer. Nature Biotechnology. 29(5). 373–374. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liv Johannessen Breakdown of academic impact, for papers by Nahee Park Breakdown of academic impact, for papers by Brian Zifcak Breakdown of academic impact, for papers by Vincent A. de Weger Breakdown of academic impact, for papers by Murray Yule Breakdown of academic impact, for papers by Mary Luz Uribe Breakdown of academic impact, for papers by Reginald B. Ewesuedo Breakdown of academic impact, for papers by Naoto Ohi Breakdown of academic impact, for papers by Tahir Sheikh
Rankless by CCL
2026